Nuo Therapeutics AURX
OTC AURX
$1.29 +0.03 (+2.46%)
As of: Oct 21, 2026 · 12:22 PM EDT

Nuo Therapeutics (AURX) Long-Term Debt Repayments (2013 - 2014)

Updated

Nuo Therapeutics (AURX) posted Long-Term Debt Repayments of $6.2 million for FY2014, up 508.0% from $1.02 million in FY2013.

Analysis

Nuo Therapeutics (AURX) Long-Term Debt Repayments (2013 - 2014) Analysis & Trends

Since FY2010, Nuo Therapeutics has reported Long-Term Debt Repayments for 4 years.

  • Annual Long-Term Debt Repayments shows a four-year compound annual growth rate of 87.0% (FY2010 to FY2014).
  • Business Quant data shows AURX's Long-Term Debt Repayments at $1.02 million in FY2013, $2.64 million in FY2011 (+421.3%) and $506,703 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 253.62 Bn 232.65 Bn 4.88 Bn -
2 Abbott Laboratories 175.99 Bn 146.42 Bn 7.27 Bn 1.41 Bn
3 Danaher 164.43 Bn 148.23 Bn 3.61 Bn -
4 Intuitive Surgical 154.62 Bn 134.04 Bn 1.96 Bn -
5 Medtronic 120.99 Bn 86.24 Bn 6.34 Bn -
6 Stryker 116.60 Bn 102.72 Bn 4.50 Bn -
7 Boston Scientific 66.31 Bn 61.08 Bn 3.85 Bn -
8 Becton Dickinson 54.00 Bn 51.14 Bn 2.32 Bn 2.00 Bn
9 Edwards Lifesciences 51.33 Bn 35.34 Bn 1.35 Bn -
10 Nuo Therapeutics 61.03 Mn 59.20 Mn 1.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 2.10 Mn
Mar 31, 2014 4.10 Mn
Dec 31, 2013 450,000.00
Sep 30, 2013 300,000.00
Jun 30, 2013 540,000.00
Mar 31, 2013 -270,000.00
API Access

Nuo Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AURX&period=max&api_key=YOUR_API_KEY